Insights in Thrombosis and In-Stent Restenosis
|
|
- Malcolm Bailey
- 6 years ago
- Views:
Transcription
1 Clinical Value of OCT Insights in Thrombosis and In-Stent Restenosis Fernando Alfonso MD, PhD, FESC Interventional Cardiology. Cardiovascular Institute. Clinico San Carlos University Hospital. Madrid. Spain. (Nothing to Disclose) ESC Munich Sunday 26 August Chairpersons: F Pratti & IRA Rashdan
2 OCT Stent Failure Stent Failure In-Stent Restenosis Stent Thrombosis (Frequent, Bening) (Rare, Major Complication) Curfman GD, Morrissey S, Jarcho JA, Drazen JM. Drug-eluting coronary stents--promise and uncertainty. N Egl J Med 2007;356(10):
3 DES ISR: Underlying Mechanisms Focal DES Fracture DES Gap Geographic Miss Uneven/Undelivered Drug Non-uniform Strut Distribution DES Damage DES Underexpansion () Hypersensitivity Drug Resistance Mechanical Factors IVUS / OCT Diffuse Biological Factors
4 Algorithm for DES ISR Treatment FFR (IVUS/OCT) (-) Medical Rx Asymptomatic Severity? DES ISR IVUS / OCT Underlying Mechanism Focal Diffuse Gap Fracture Edge Body DES DES DES Underexpansion? Avoid Geo Miss Pressure NC BA Optimization Prefered DES: Hetero DES & 2nd G Favor PEB: Multiple ST layers, major SB DES / PEB
5 Intravascular Ultrasound Assessment of In-ST Restenosis? RIBS: 214 BD: 5338
6 Intracoronary Imaging In-ST Restenosis IVUS OCT
7 DES Fractures DES Fractures: Pathology of DES Fractures: DES fracture & ISR Nakazawa G, et al. J Am Coll Cardiol 2009;54:
8 DES Fractures DES Fractures: OCT for restenosis evaluation. Identification of the mechanism Clinico San Carlos University Hospital # IVUS #3412
9 ISR OCT vs IVUS Neointima As compared with histology, the diagnostic accuracy of OCT (AUC 0.967) was higher than that of IVUS (AUC 0.781) Suzuki Y Fearon WF. J Am Coll Cardiol Intv 2008;1:168 73)
10 Gonzalo N, et al. Am Heart J 2009;158: OCT-ISR
11 OCT-ISR 24 Patients ISR (4 BMS, 21 DES) Heterogeneous & low backsactter: Focal ISR Layered appearance: ISR >12 months Irregular lumen shape: Unstable angina Gonzalo N, et al. Am Heart J 2009;158:284-93
12 OCT-ISR Irregular Lumen Intraluminal Material (Irregular lumen shape 28%. Intraluminal material 20%) Gonzalo N, et al. Am Heart J 2009;158:284-93
13 OCT-ISR Focal ISR: Heterogeneous Tissue, Low Backscatter Gonzalo N, et al. Am Heart J 2009;158:284-93
14 OCT-ISR Diffuse ISR: Layered, High Backscatter (Layered in 52%, homogeneous in 28%, and heterogeneous in 20%) Gonzalo N, et al. Am Heart J 2009;158:284-93
15 OCT-ISR Layered ISR VCP DB # (9M FU RIBS 4)
16 OCT-ISR DES Follow-up: 192 non-isr lesions vs 33 ISR lesions Layered Low backscatter Heterogeneous Microvessels Lee SJ et al. Clin Cardiol 2011 Oct;34(10):633-9.
17 OCT-ISR (Microvessels) 78 ISR lesions (72 DES, 6 BMS) 21 (27%) had microvessels. (Microvessels: low backscattering structures <200 μm in diameter) Microvessels associated with: Neointimal hyperplasia (NIH) CSA (5.4 vs 4.2 mm²; p=0.024) % NIH CSA (79 vs 67%; p=0.001). Kim BK et al. J Invasive Cardiol 2012 Mar;24(3):
18 OCT-ISR PEB for ISR Neointimal Healing Patterns after Paclitaxel-Eluting Balloon Therapy Of Drug-Eluting Stent Restenosis - 80-year-old man, stable angina, EES (2.75x12 mm), proximal LAD - 3 years later severe edge ISR - RIBS IV (PEB) (3x15 mm) - 9 month FU Sandoval J, Alfonso F. J Invas Cardiol 2012 (In press)
19 OCT-ISR PEB for ISR (Acute) A B C D E F Sandoval J, Alfonso F. J Invas Cardiol 2012 (In press) 2/6/2011 RIBS IV (DB #52323, # )
20 OCT-ISR PEB for ISR (Follow-up) A B C D E F Sandoval J, Alfonso F. J Invas Cardiol 2012 (In press) 2/6/2011 RIBS IV (DB #52323, # )
21 Secco GG. EuroIntervention 2011;7: OCT-ISR
22 OCT-ISR Calcified ISR Challenging Treatment of Calcified ISR Dilation Failure Bail Out Rotational Atherectomy A 77-year-old man on hemodialysis was investigated for unstable angina. - Coronary angiography revealed ISR of a bare metal stent that had been implanted in the right coronary artery 10 years before Alfonso F. Calcified In-Stent Restenosis : A Rare Cause of Dilation Failure Requiring Rotational Atherectomy. Circ Cardiovasc Interv 2012;5;e1-e2.
23 OCT-ISR Calcified ISR B A E C D Alfonso F. Calcified In-Stent Restenosis : A Rare Cause of Dilation Failure Requiring Rotational Atherectomy. Circ Cardiovasc Interv 2012;5;e1-e2.
24 OCT-ISR A Calcified ISR B C Alfonso F. Calcified In-Stent Restenosis : A Rare Cause of Dilation Failure Requiring Rotational Atherectomy. Circ Cardiovasc Interv 2012;5;e1-e2.
25 OCT-ISR Neoatherosclerosis: Elusive Link From ISR to ST?
26 OCT-ISR Contribution of organized thrombus to SES ISR (12 Mo FU) Fujii K Eur Heart J 2008 Jun;29(11):1385
27 OCT-ISR Detection of atherosclerotic progression with rupture of degenerated instent intima 5 years after BMS implantation by OCT Habara M, et al. J Invasive Cardiol 2009 Oct;21(10):552-3
28 OCT-ISR 39 Pts (60 BMS) average time to OCT 6.5 years. Features of lipid-rich plaque was found in 20 stents (33.3%) in 16 patients (41%). Average fibrous cap thickness was 56.7 um Lipid arc was 173º. 6 patients had plaque disruption 6 patients had mural thrombus. Hypertension and smoking were more common Hou J et al. Heart 2010 Aug;96(15):
29 Neoatherosclerosis & ISR Newly Formed Atherosclerotic Changes Within Neointima After Stent Implantation SES implanted for 13 months Foamy macrophage clusters in the peristrut region Fibroatheroma with foamy macrophage-rich lesion and early necrotic core Fibroatheroma, peristrut early necrotic core, cholesterol clefts, surface foamy macrophages, and early calcification (arrows) Nakazawa G, Virmani R. J Am Coll Cardiol 2011;57:
30 OCT: Early vs Very Late BMS ISR 9-Mo FU after BMS 8Y FU after BMS Habara M, et al. Circ Cardiovasc Interv 2011 Jun;4(3):232-8
31 OCT DES ISR: Pathophysiology OCT in 50 Pts with DES ISR 58% Rupture, 52% TCFA, 58% Thrombus Rupture TCFA Microvessels Thrombus TCFA Rupture Kang SJ, Mintz GS. Circulation. 2011;123:
32 OCT-ISR Limitations OCT to Detect Neoatherosclerosis (The pathologist s perspective) 1.- OCT cannot discern the newly formed atherosclerosis within stent from the metal strut penetration into the preexisting necrotic core. DES strut penetration into necrotic core leads to delayed arterial healing or subtle neointimal coverage, which might be recognized as a new lesion of TCFA with or without intimal disruption by OCT. 2.- Fibrin accumulation is frequently observed around the struts of paclitaxeleluting stents. Massive fibrin accumulation is seen on OCT as a dark area without a clear border, which resembles necrotic core. 3.- Limitations of OCT to identify foamy macrophages on the luminal surface of neointima, with a typical appearance of a thin bright line with trailing shadows. This feature mimics the so-called OCT-derived TCFA and prevents assessment of deeper tissues. 4.- Accumulated macrophages are fragile, easily cracked (wire or catheter), and will end up with discontinuation or disruption in neointimal surface. (Letter) Nakano M Virmani R. Circulation Dec 20;124(25):e954
33 OCT-ST BMS ST Thrombus Rupture TCFA Macrophage Thrombus Aspirration Low Intensity Ca Karanasos A, Ligthardt J, Regar E. JACC CV Interv 2012; 5:
34 OCT-ISR A ISR Presenting as ST B C D T T Alfonso F, New Insights on Stent Thrombosis. JACC Cardiovasc Interv Feb;5(2): RIBS (14/10/2011)
35 OCT-ISR Ruptured Neoatherosclerosis The elusive link between very late ISR and ST 55 year-old man presenting with NSTEMI ( ST V1-V4). (8 years ago: BMS LCX. 6 Mo excellent BMS result)?? Alfonso F, (PRESTIGE Study) PRESTIGE (13/08/2012)
36 OCT-ISR Ruptured Neoatherosclerosis A The elusive link between very late ISR and ST B C T E D C B D E Alfonso F, (PRESTIGE Study) PRESTIGE (13/08/2012)
37 OCT- ST Stent Thrombosis
38 OCT-ST DETECTIVE STEMI (MVD) Early (3-7d) Healing % ST Coverage (88%) % Uncoverage DES / CCS; Non-culprit/Culprit Covered Malapposition Thrombus Prati F, et al. Heart 2011;97; Uncoverage
39 IVUS & OCT Malapposition Alfonso F, RIBS IV, Clinico San Carlos University Hospital
40 OCT-ST In STEMI patients PES as compared with BMS significantly reduces neointimal hyperplasia but results in higher rates of uncovered and malapposed stent at 13-month follow-up. Guagliumi G, et al. Circulation. 2011;123:
41 OCT-ST Evolving Stent Thrombosis? Zakehn B, Ortiz A, Alfonso F. J Invasive Cardiol 2011;23:E222 E225
42 OCT-ST Evolving Stent Thrombosis Spider Web like Spider Web like Swiss Cheese like Swiss Cheese like Zakehn B, Ortiz A, Alfonso F. J Invasive Cardiol 2011;23:E222 E225
43 Cho JM, Jang JK. J Am Coll Cardiol 2010;55:1274. OCT-ISR
44 OCT-ST 18 Pts Late DES ST vs 36 Controls OCT: Patients with LST had a higher % of: - uncovered struts (12.3 vs. 4.1, p< 0.001) - malapposed struts (4.6 vs. 1.8, p< 0.001) IVUS: Patients with LST had positive remodeling - Vessel area 19.4 mm2 vs mm2 (p< 0.003). Independent predictors of LST: - length of segment with uncovered stent by OCT - remodeling index by IVUS Guagliumi G, et al. J Am Coll Cardiol Intv 2012;5:12 20
45 Guagliumi G, et al. J Am Coll Cardiol Intv 2012;5:12 20 OCT-ST
46 OCT-ST 15 Patients ST with OCT & IVUS (before and after PCI) 7 DES / 8 BMS (Median time 347 days) All Patients AMI (11STEMI, 4 NSTEMI) Peak CPK: 2,4352,606 IU Alfonso F, et al. Heart 2012;98:1213e1220
47 OCT-ST A 1 T A2 T B1 B2 T T T T Alfonso F, et al. Heart 2012;98:1213e1220
48 A1 OCT-ST A2 T T B1 B2 Alfonso F, et al. Heart 2012;98:1213e1220
49 OCT-ST A B T C T D E F T T T T D T SB Alfonso F, et al. Heart 2012;98:1213e1220
50 OCT-ST Intra-Stent: Edge-related Dissections MNA Alfonso F, et al. Heart 2012;98:1213e1220
51 OCT-ST OCT Findings at Rescue Interventions Stent Before After Minimal area (mm 2 ) Minimal expansion (%) Severe underexpansion 13 (87%) 6 (40%) Asymmetry Thrombus 15 (100%) 15 (100%) Red/White/Both 7/1/7 7/1/7 Shadowing Length (mm) Maximal TH area (mm 2 ) Residual lumen (mm 2 ) Maximal obstruction (%) Alfonso F, et al. Heart 2012;98:1213e1220
52 OCT-ST A B Alfonso F, et al. Circ Cardiovasc Interv. 2011;4:
53 A OCT-ST B C D Alfonso F. Circ Cardiovasc Interv 2011;4; ;
54 OCT-ST A B C Alfonso F, et al. Circ Cardiovasc Interv. 2011;4:
55 OCT Stent Failure Stent Failure In-Stent Restenosis Stent Thrombosis T (Frequent, Bening) (Rare, PRESTIGE Major (13/08/2012) Complication) Curfman GD, Morrissey S, Jarcho JA, Drazen JM. Drug-eluting coronary stents--promise and uncertainty. N Egl J Med 2007;356(10):
2yrs 2-6yrs >6yrs BMS 0% 22% 42% DES 29% 41% Nakazawa et al. J Am Coll Cardiol 2011;57:
Pathology of In-stent Neoatherosclerosis in BMS and DES 197 BMS, 103 SES, and 106 PES with implant duration >30 days The incidence of neoatherosclerosis was significantly greater in DES (31%) than BMS
More informationTratamiento de la Reestenosis del Stent Farmacoactivo
XXXI Jornadas SOLACI. 10ª Región CONOSUR LIIIº Congreso Chileno de Cardiología y Cirugía Cardiovascular Hotel Patagónico. Puerto Varas. Chile (30 Nov 1 Dic 2016) Tratamiento de la Reestenosis del Stent
More informationas a Mechanism of Stent Failure
In-Stent t Neoatherosclerosis e osc e os s as a Mechanism of Stent Failure Soo-Jin Kang MD., PhD. University of Ulsan College of Medicine, Heart Institute Asan Medical Center, Seoul, Korea Disclosure I
More informationQue nos puede aportar el OCT intracoronario
XXXI Jornadas SOLACI. 10ª Región CONOSUR LIIIº Congreso Chileno de Cardiología y Cirugía Cardiovascular Hotel Patagónico. Puerto Varas. Chile (30 Nov 1 Dic 2016) Que nos puede aportar el OCT intracoronario
More informationCLINICAL APPLICATIONS OF OPTICAL COHERENCE TOMOGRAPHY. Konstantina P. Bouki, FESC 2 nd Department of Cardiology General Hospital Of Nikea, Pireaus
CLINICAL APPLICATIONS OF OPTICAL COHERENCE TOMOGRAPHY Konstantina P. Bouki, FESC 2 nd Department of Cardiology General Hospital Of Nikea, Pireaus OPTICAL COHERENCE TOMOGRAPHY (OCT) IVUS and OCT IVUS OCT
More informationCatch-up Phenomenon: Insights from Pathology
Catch-up Phenomenon: Insights from Pathology Michael Joner, MD CVPath Institute Inc. Gaithersburg, MD USA Path Lessons learned from the BMS and DES (1 st Gen) era Neointimal Thickness [mm] In Stent Re
More informationImaging Atheroma The quest for the Vulnerable Plaque
Imaging Atheroma The quest for the Vulnerable Plaque P.J. de Feijter 1. Department of Cardiology 2. Department of Radiology Coronary Heart Disease Remains the Leading Cause of Death in the U.S, Causing
More informationOCT Findings: Lesson from Stable vs Unstable Plaques
ANGIOPLASTY SUMMIT TCTAP 2010 Imaging Workshop OCT Findings: Lesson from Stable vs Unstable Plaques Giulio Guagliumi MD Ospedali Riuniti di Bergamo, Italy DISCLOSURE OF FINANCIAL INTERESTS Consultant Boston
More informationClinical Value of OCT. Guidance for Coronary Stenting. Giulio Guagliumi, MD
Clinical Value of OCT Guidance for Coronary Stenting Giulio Guagliumi, MD 100 % Endovascular Imaging Indications of use 87.5 % 75 % 57.5 % 50 % 45 % 25 % 15 % 0 Lesion morphology Stent optimization Lesion
More informationIVUS Analysis. Myeong-Ki. Hong, MD, PhD. Cardiac Center, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea
IVUS Analysis Myeong-Ki Hong, MD, PhD Cardiac Center, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea Intimal disease (plaque) is dense and will appear white Media is made of
More informationCan IVUS Define Plaque Features that Impact Patient Care?
Can IVUS Define Plaque Features that Impact Patient Care? A Pichard L Satler, K Kent, R Waksman, W Suddath, N Bernardo, N Weissman, M Angelo, D Harrington, J Lindsay, J Panza. Washington Hospital Center
More informationOptical Coherence Tomography for Intracoronary Imaging
Optical Coherence Tomography for Intracoronary Imaging Lorenz Räber Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical Trials Unit Bern Bern University Hospital, Switzerland
More informationOCT; Comparative Imaging Results with IVUS, VH and Angioscopy
OCT; Comparative Imaging Results with IVUS, VH and Angioscopy Takashi Akasaka, M.D. Department of Cardiovascular Medicine Wakayama, Japan Comparison among coronary imaging techniques OCT IVUS MRI CAG Angioscopy
More informationIN-STENT RESTENOSIS. K.Boerlage-van Dijk CarVasZ 2014
IN-STENT RESTENOSIS K.Boerlage-van Dijk CarVasZ 2014 Definition ISR Angiographic: recurrent diameter stenosis >50% at the stent segment or edges (5-mm segments adjacent to stent) Mehran system morphological
More informationOptical coherence tomography patterns of in-stent restenosis: Comparison between bare-metal stent and drug-eluting stent
Optical coherence tomography patterns of in-stent restenosis: Comparison between bare-metal stent and drug-eluting stent heart institute, Division of cardiology, Tokyo, Japan Yusuke Watanabe, Ryuta Asano,
More informationAdded Value of Invasive Coronary Imaging for Plaque Rupture and Erosion
Assessment of Coronary Plaque Rupture and Erosion Added Value of Invasive Coronary Imaging for Plaque Rupture and Erosion Yukio Ozaki, MD, PhD, FACC, FESC Cardiology Dept., Fujita Health Univ. Toyoake,
More informationLeft main coronary artery (LMCA): The proximal segment
Anatomy and Pathology of Left main coronary artery G Nakazawa Tokai Univ. Kanagawa, Japan 1 Anatomy Difinition Left main coronary artery (LMCA): The proximal segment RCA AV LAD LM LCX of the left coronary
More informationIn-stent Restenosis Diagnostic and Therapeutic Challenges. Kostis Raisakis General Hospital of Athens «G. Gennimatas»
In-stent Restenosis Diagnostic and Therapeutic Challenges Kostis Raisakis General Hospital of Athens «G. Gennimatas» Introduction With POBA, rates of acute and chronic vessel occlusion at 30% to 60%, secondary
More informationCulprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome
Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome Hiroyuki Okura*, MD; Nobuya Matsushita**,MD Kenji Shimeno**, MD; Hiroyuki Yamaghishi**, MD Iku Toda**,
More informationDES In-stent Restenosis
DES In-stent Restenosis Roxana Mehran, MD Columbia University Medical Center The Cardiovascular Research Foundation DES Restenosis Mechanisms Predictors Morphological patterns Therapy approach Mechanisms
More informationImaging Overview for Vulnerable Plaque: Data from IVUS Trial and An Introduction to VH-IVUS Imgaging
Imaging Overview for Vulnerable Plaque: Data from IVUS Trial and An Introduction to VH-IVUS Imgaging Gary S. Mintz,, MD Cardiovascular Research Foundation New York, NY Today, in reality, almost everything
More informationComplex PCI. Your partner in complex PCI: In-stent restenosis (ISR)
Comple PCI Your partner in comple PCI: Your partner in comple PCI: Philips provides a portfolio of specialty coronary diagnostic and therapy devices that enable safe and effective treatment of a wide variety
More informationMuzina Akhtar, Wei Liu. History of ISR visualization. Introduction
Perspective Use of intravascular ultrasound vs. optical coherence tomography for mechanism and patterns of in-stent restenosis among bare metal stents and drug eluting stents Muzina Akhtar, Wei Liu Cardiology
More informationDrug eluting stents (DES) have decreased
JACC: CARDIOVASCULAR IMAGING VOL. 5, NO. 11, 1 1 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-878X/$36. PUBLISHED BY ELSEVIER INC. http://dx.doi.org/1.116/j.jcmg.1.. BRIEF REPORT OCT-Verified
More informationInvasive Coronary Imaging Modalities for Vulnerable Plaque Detection
Invasive Coronary Imaging Modalities for Vulnerable Plaque Detection Gary S. Mintz, MD Cardiovascular Research Foundation New York, NY Greyscale IVUS studies have shown Plaque ruptures do not occur randomly
More informationReview Article Pathologic Etiologies of Late and Very Late Stent Thrombosis following First-Generation Drug-Eluting Stent Placement
ombosis Volume 2012, Article ID 608593, 16 pages doi:10.1155/2012/608593 Review Article Pathologic Etiologies of Late and Very Late Stent ombosis following First-Generation Drug-Eluting Stent Placement
More information1st Department of Cardiology, University of Athens, Hippokration Hospital, Athens, Greece
Konstantinos Toutouzas, Maria Riga, Antonios Karanasos, Eleftherios Tsiamis, Andreas Synetos, Maria Drakopoulou, Chrysoula Patsa, Georgia Triantafyllou, Aris Androulakis, Christodoulos Stefanadis 1st Department
More informationIVUS Assessment of the Mechanism of In-stent Restenosis? Gary S. Mintz, MD Cardiovascular Research Foundation
IVUS Assessment of the Mechanism of In-stent Restenosis? Gary S. Mintz, MD Cardiovascular Research Foundation SURE Trial: Restenosis in non-stented lesions Average of the two image slices with the smallest
More informationΑγγειοπλαστική σε Eπαναστενωτικές Bλάβες
Αγγειοπλαστική σε Eπαναστενωτικές Bλάβες Βάιος Π. Τζίφος Δ/ντής Γ Καρδιολογικής Κλινικής - Επεμβατικής Καρδιολογίας. Ερρίκος Ντυνάν HC The Mehran s Classification for BMS-ISR Prognostic Value Pattern (1)
More informationmalapposition assessed by OCT
Stent t coverage and malapposition assessed by OCT Myeong-Ki Hong, M.D. Ph D Professor of Medicine Division of Cardiology, Severance Cardiovascular Hospital Yonsei University College of Medicine, Seoul,
More informationInvasive Imaging (IVUS, VH-IVUS, and OCT): How I Implement into My
Invasive Imaging (IVUS, VH-IVUS, and OCT): How I Implement into My Practice Gary S. Mintz, MD Cardiovascular Research Foundation Modalities FFR IVUS (with or without VH, imap, or IB-IVUS) OCT NIRS (with
More informationΚλινική Χρήση IVUS και OCT PERIKLIS A. DAVLOUROS ASSOCIATE PROFESSOR OF CARDIOLOGY INVASIVE CARDIOLOGY & CONGENITAL HEART DISEASE
Κλινική Χρήση IVUS και OCT PERIKLIS A. DAVLOUROS ASSOCIATE PROFESSOR OF CARDIOLOGY INVASIVE CARDIOLOGY & CONGENITAL HEART DISEASE Conflict of interest None to declare While IVUS is the most used intravascular
More informationUsefulness of OCT during coronary intervention
Usefulness of OCT during coronary intervention Takashi Akasaka, M.D. Department of Cardiovascular Medicine Wakayama, Japan Predictors at 12 Months of Stent Thrombosis and Target Lesion Revascularization
More informationOCT GUIDED TREATMENT OF CALCIFIED LESIONS RICHARD SHLOFMITZ, MD CHAIRMAN OF DEPT. OF CARDIOLOGY ST. FRANCIS HOSPITAL ROSLYN, NEW YORK
OCT GUIDED TREATMENT OF CALCIFIED LESIONS RICHARD SHLOFMITZ, MD CHAIRMAN OF DEPT. OF CARDIOLOGY ST. FRANCIS HOSPITAL ROSLYN, NEW YORK Disclosure Statement of Financial Interest Within the past 12 months,
More informationEvaluation of stent placement and outcomes with optical coherence tomography
REVIEW Evaluation of stent placement and outcomes with optical coherence tomography Optical coherence tomography (OCT) is an imaging modality based on fiberoptic technology. OCT imaging systems use optical
More informationPost PCI functional testing and imaging: case based lessons from FFR React
Post PCI functional testing and imaging: case based lessons from FFR React Joost Daemen, MD, PhD, FESC Optics in Cardiology 2018 April 21st, 2018 10.15 10.30h Disclosure Statement of Financial Interest
More informationDrug eluting balloons in CAD
Drug eluting balloons in CAD Ioannis Iakovou, MD, PhD Interventional Cardiology 1 st Cath Lab Onassis Cardiac Surgery Center Drug-Eluting Balloons (DEB) Technology and Applications 1. Special Features
More informationDavide Capodanno, MD, PhD Associate Professor, University of Catania, Italy
Restenosis - Capodanno CardioLucca, November 28, 2014 Slide 1 Autumn in Lucca V Simposio - 28 Novembre 2014 4.30PM-4.45PM L incubo del paziente e le incognite del cardiologo: la restenosi intrastent resta
More informationNeointimal coverage of bare-metal and sirolimuseluting stents evaluated with optical coherence tomography
Neointimal coverage of bare-metal and sirolimuseluting stents evaluated with optical coherence tomography B X Chen, F Y Ma, W Luo, J H Ruan, W L Xie, X Z Zhao, S H Sun, X M Guo, F Wang, T Tian, X W Chu
More informationAnalysis of macrophage accumulation using optical coherence tomography one year after sirolimus, paclitaxel and zotarolimus-eluting stent
Analysis of macrophage accumulation using optical coherence tomography one year after sirolimus, paclitaxel and zotarolimus-eluting stent implantation. Department of Cardiology, Ehime Prefectural Imabari
More informationPlaque Characteristics in Coronary Artery Disease. Chourmouzios Arampatzis MD, PhD, FESC
Plaque Characteristics in Coronary Artery Disease Chourmouzios Arampatzis MD, PhD, FESC Disclosure Statement of Financial Interest Regarding this Presentation NONE Atherosclerosis Model proposed by Stary
More informationOCT Technology: Differences between Biodegradable and Durable Polymers: Insights from the LEADERS Trial LEADERS OCT
OCT Technology: Differences between Biodegradable and Durable Polymers: Insights from the LEADERS Trial LEADERS OCT Substudy Carlo Di Mario, MD Peter Barlis, MD Evelyn Regar, MD Peter Juni, MD Patrick
More informationOCT in the Evaluation of Vascular Healing Following DES Implantation: Will It Be a Helpful Tool to Reduce Stent Thrombosis?
OCT in the Evaluation of Vascular Healing Following DES Implantation: Will It Be a Helpful Tool to Reduce Stent Thrombosis? Juan F. Granada, MD Medical Director, Skirball Center for Cardiovascular Research
More informationIntracoronary Imaging For Complex PCI A Pichard, L Satler, Ron Waksman, I Ben-Dor, W Suddath, N Bernardo, D Harrington.
Intracoronary Imaging For Complex PCI A Pichard, L Satler, Ron Waksman, I Ben-Dor, W Suddath, N Bernardo, D Harrington. Medstar Washington Hospital Center Washington, DC Conflict of Interest None for this
More informationAssessment of Vulnerable Plaque by IVUS and VH-IVUS
Assessment of Vulnerable Plaque by IVUS and VH-IVUS Akiko Maehara, MD Director of Intravascular Imaging & Physiology Core Laboratories Associate Director of MRI/MDCT Core Laboratory Cardiovascular Research
More informationAppearance of Lipid-Laden Intima and Neovascularization After Implantation of Bare-Metal Stents
Journal of the American College of Cardiology Vol. 55, No. 1, 2010 2010 by the American College of Cardiology Foundation ISSN 0735-1097/10/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2009.08.032
More informationIntravascular Ultrasound
May 2008 Beth Israel Deaconess Medical Center Harvard Medical School Intravascular Ultrasound Matthew Altman, HMS III Gillian Lieberman, MD BIDMC Department of Radiology Presentation Overview 1. Patient
More informationIntegrating IVUS, FFR, and Noninvasive Imaging to Optimize Outcomes. Gary S. Mintz, MD Cardiovascular Research Foundation
Integrating IVUS, FFR, and Noninvasive Imaging to Optimize Outcomes Gary S. Mintz, MD Cardiovascular Research Foundation COURAGE Nuclear Substudy (n=314) Death/MI according the residual ischemia (SPECT)
More informationJACC: CARDIOVASCULAR INTERVENTIONS VOL. 2, NO. 5, PUBLISHED BY ELSEVIER INC. DOI: /j.jcin
JACC: CARDIOVASCULAR INTERVENTIONS VOL. 2, NO. 5, 2009 2009 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/09/$36.00 PUBLISHED BY ELSEVIER INC. DOI: 10.1016/j.jcin.2009.01.012 Incomplete
More informationVulnerable Plaque Pathophysiology, Detection, and Intervention. VP: A Local Problem or Systemic Disease. Erling Falk, Denmark
Vulnerable Plaque Pathophysiology, Detection, and Intervention VP: A Local Problem or Systemic Disease Erling Falk, Denmark Vulnerable Plaque Pathophysiology, Detection, and Intervention VP: A Local Problem
More informationOCT Analysis in Patients With Very Late Stent Thrombosis
JACC: CARDIOVASCULAR IMAGING VOL. 6, NO. 6, 2013 ª 2013 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-878X/$36.00 PUBLISHED BY ELSEVIER INC. http://dx.doi.org/10.1016/j.jcmg.2013.02.006 OCT
More informationTLR des Stents Actifs
TLR des Stents Actifs No Conflict of Interest Target Lesion Revascularization DES vs BMS Stettler C et al. Lancet 2007;370:937-48 N=18,023 58% 70% SES vs BMS: HR=0.30 (0.24-0.37), p
More informationIVUS vs FFR Debate: IVUS-Guided PCI
IVUS vs FFR Debate: IVUS-Guided PCI Gary S. Mintz, MD Cardiovascular Research Foundation New York, NY Disclosure Statement of Financial Interest Within the past 12 months, I have had a financial interest/arrangement
More informationDeclaration of conflict of interest. Nothing to disclose
Declaration of conflict of interest Nothing to disclose Hong-Seok Lim, Seung-Jea Tahk, Hyoung-Mo Yang, Jin-Woo Kim, Kyoung- Woo Seo, Byoung-Joo Choi, So-Yeon Choi, Myeong-Ho Yoon, Gyo-Seung Hwang, Joon-Han
More informationBifurcation stenting with BVS
Bifurcation stenting with BVS Breaking the limits or just breaking the struts? Maciej Lesiak Department of Cardiology University Hospital in Poznan, Poland Disclosure Speaker s name: Maciej Lesiak I have
More informationCPIS So-Yeon Choi, MD., PhD. Department of Cardiology Ajou University School of MedicineSuwon, Korea
So-Yeon Choi, MD., PhD. Department of Cardiology Ajou University School of MedicineSuwon, Korea Coronary Artery Imaging The ideal coronary imaging technology would be capable of identifying not only vessel
More informationNext Generation Drug- eluting Stent : Will It Solve the Problem?
Next Generation Drug- eluting Stent : Will It Solve the Problem? Yangsoo Jang, M.D., Ph.D, FACC Severance Cardiovascular Hospital Yonsei University Healthcare System Commercially Available DES An Epidemic
More informationPathology of Vulnerable Plaque Angioplasty Summit 2005 TCT Asia Pacific, Seoul, April 28-30, 2005
Pathology of Vulnerable Plaque Angioplasty Summit 25 TCT Asia Pacific, Seoul, April 28-3, 25 Renu Virmani, MD CVPath, A Research Service of the International Registry of Pathology Gaithersburg, MD Plaque
More informationCardiovascular Research Foundation and Columbia University Medical Center, New York.
Virtual Histology Intravascular Ultrasound Analysis of Non-culprit Attenuated Plaques Detected by Grayscale Intravascular Ultrasound in Patients with Acute Coronary Syndromes Xiaofan Wu, Akiko Maehara,
More informationPCI for In-Stent Restenosis. CardioVascular Research Foundation
PCI for In-Stent Restenosis ISR of BMS Patterns of In-Stent Restenosis Pattern I : Focal Type IA: Articulation / Gap Type IB: Marginal Type IC: Focal body Type ID: Multifocal Pattern II,III,IV : Diffuse
More informationRESTENOSIS Facing up to the problem
RESTENOSIS Facing up to the problem Petr Kala University Hospital Brno Czech Republic ESC 2011, Paris Disclosure Scientific Advisory Boards or Education presentations fee Abbott, Boston Scientific, Cordis
More informationReview Article Optical Coherence Tomography Imaging in Acute Coronary Syndromes
SAGE-Hindawi Access to Research Cardiology Research and Practice Volume 2011, Article ID 312978, 7 pages doi:10.4061/2011/312978 Review Article Optical Coherence Tomography Imaging in Acute Coronary Syndromes
More informationCover Page. Author: Wang, Ancong Title: Automatic quantification of intravascular optical coherence tomography Issue Date:
Cover Page The handle http://hdl.handle.net/1887/29690 holds various files of this Leiden University dissertation Author: Wang, Ancong Title: Automatic quantification of intravascular optical coherence
More informationOptical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents
Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents J-S Kim, 1 I-K Jang, 2 J-S Kim, 1 T H Kim, 1 M Takano, 3 T Kume, 4 N
More informationClinical Application of OCT in Stent Evaluation
Imaging & Physiology Summit 2010 in Soul #1. Basics of Image Interpretation: IVUS/VH/OCT Clinical Application of OCT in Stent Evaluation Mitsuyasu Terashima, MD, PhD, FACC Stent implantation Stent Apposition
More informationThe BIO revolution: bioadsorbable stents. Federico Conrotto Cardiologia 2 Città della Salute e della Scienza di Torino
The BIO revolution: bioadsorbable stents Federico Conrotto Cardiologia 2 Città della Salute e della Scienza di Torino BVS stent (Abbot Vascular) Strut Material: Poly-L-Lactic acid Coating Material: Poly-D,L-lactide
More informationShedding light on stent thrombosis
Editorial Shedding light on stent thrombosis Tawfiq Choudhury 1,2, Rodrigo Bagur 1,2, Ashlay A. Huitema 1,2, Amir Solomonica 1,2, Shahar Lavi 1,2 1 Department of Medicine, Western University, London, ON,
More informationPrognostic Value of Gated Myocardial Perfusion SPECT
Current Use of IVUS & FFR George D. Dangas, MD, PhD, FACC, FSCAI Professor of Medicine Mount Sinai School of Medicine Prognostic Value of Gated Myocardial Perfusion SPECT 0.6% / year, Cardiac Death and
More informationAnalysis of neointimal coverage after silolimus-eluting stent implantation using optical coherence tomography.
Analysis of neointimal coverage after silolimus-eluting stent implantation using optical coherence tomography. Division of Cardiology, Department of Internal Medicine, Fasculty of Medicine, Kinki University,
More informationShockwave Intravascular Lithotripsy System treatment of calcified lesions: Intravascular OCT analysis
Shockwave Intravascular Lithotripsy System treatment of calcified lesions: Intravascular OCT analysis Andrew Holden, MBChB, FRANZCR, EBIR Director of Interventional Radiology Auckland, New Zealand LINC
More informationAssessment of plaque morphology by OCT in patients with ACS
Assessment of plaque morphology by OCT in patients with ACS Takashi Akasaka, M.D. Department of Cardiovascular Medicine Wakayama, Japan Unstable plaque Intima Lipid core Plaque rupture and coronary events
More informationIncidence and Treatment for LM In-Stent
Incidence and Treatment for LM In-Stent Restenosis Corrado Tamburino, MD, PhD Full Professor of Cardiology, Director of Postgraduate School of Cardiology Chief Cardiovascular Department, Director Cardiology
More informationOptical Coherence Tomography
Optical Coherence Tomography Disclosure Information Demetrius Lopes MD The following relationships exist related to this presentation: University Grant/Research Support: Rush University Industry Grant
More informationThe PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque
The PROSPECT Trial Providing Regional Observations to Study Predictors of Events in the Coronary Tree A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively
More informationPCI for Long Coronary Lesion
PCI for Long Coronary Lesion Shift of a General Idea with the Introduction of DES In the Bare Metal Stent Era Higher Restenosis Rate With Increasing Stent Length and Decreasing Stent Area Restenosis.6.4.2
More informationDID OCT change our experience on coronary arteries?
DID OCT change our experience on coronary arteries? Istanbul June 2012 F Prati San Giovanni Hospital, Rome Rome Heart Research Use imaging modalities to.. Avoid useless procedures! MLA of 2.0 mm 2 best
More informationActa Cardiol Sin 2018;34: doi: /ACS _34(2) A
Original Article Acta Cardiol Sin 2018;34:124 129 doi: 10.6515/ACS.201803_34(2).20171115A Coronary Artery Disease Vascular Healing Response after Everolimus-Eluting Stent Implantation in Acute Coronary
More informationSites of Atherosclerosis In order of Frequency
Pathological Features of Peripheral Atherosclerosis: Implication for Device Development G Nakazawa Tokai Univ. Kanagawa, Japan 1 Sites of Atherosclerosis In order of Frequency carotid (3) (3) Coronary
More informationHCS Working Group Seminars Macedonia Pallas Hotel, Friday 21 st February Drug-eluting stents Are they all equal?
HCS Working Group Seminars Macedonia Pallas Hotel, Friday 21 st February 2014 Drug-eluting stents Are they all equal? Vassilis Spanos Interventional Cardiologist, As. Director 3 rd Cardiology Clinic Euroclinic
More informationWhat Coronary Specialists Teach The Vascular Community About Vessel Prep? Tony Das, MD Texas Health, Dallas Dallas, Texas
What Coronary Specialists Teach The Vascular Community About Vessel Prep? Tony Das, MD Texas Health, Dallas Dallas, Texas Stent Era Lessons on Vessel Preparation Under expanded stent consequences Abrupt
More informationDEB experience in Gachon Universtiy Gil Hospital (in ISR) Soon Yong Suh MD., PhD. Heart Center Gachon University Gil Hospital Seoul, Korea.
DEB experience in Gachon Universtiy Gil Hospital (in ISR) Soon Yong Suh MD., PhD. Heart Center Gachon University Gil Hospital Seoul, Korea. In-stent restenosis (ISR) Remains important issue even in the
More informationStent strut coverage of titanium-nitride-oxide coated stent compared to paclitaxel-eluting stent in acute myocardial infarction: TITAX-OCT study
DOI 10.1007/s10554-012-0032-6 ORIGINAL PAPER Stent strut coverage of titanium-nitride-oxide coated stent compared to paclitaxel-eluting stent in acute myocardial infarction: TITAX-OCT study Tuomas Lehtinen
More informationResearch Article Pathological Perspective of Drug-Eluting Stent Thrombosis
Thrombosis Volume 2012, Article ID 219389, 8 pages doi:10.1155/2012/219389 Research Article Pathological Perspective of Drug-Eluting Stent Thrombosis Katsumi Inoue Department of Laboratory Medicine, Kokura
More informationIndex. B Bare metal stents (BMS) vs. DES, 172 OCT findings, 170, 172
Index A Absorbable metal stent (AMS), 189 Absorb BVS, 184 187 Acquired malapposition in DES, stent thrombosis. See also Incomplete stent apposition (ISA) coronary angiography, 155, 156 DAPT therapy, 155
More informationA Novel Low Pressure Self Expanding Nitinol Coronary Stent (vprotect): Device Design and FIH Experience
A Novel Low Pressure Self Expanding Nitinol Coronary Stent (vprotect): Device Design and FIH Experience Juan F. Granada, MD Medical Director, Skirball Center for Cardiovascular Research The Cardiovascular
More informationLe# main treatment with Stentys stent. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy
Le# main treatment with Stentys stent Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy Disclosure Statement of Financial Interest I, Carlo Briguori DO NOT have a financial interest/ arrangement
More informationThe PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque
The PROSPECT Trial Providing Regional Observations to Study Predictors of Events in the Coronary Tree A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively
More informationSMJ Singapore Medical Journal
SMJ Singapore Medical Journal ONLINE FIRST PUBLICATION Online first papers have undergone full scientific review and copyediting, but have not been typeset or proofread. To cite this article, use the DOIs
More informationTechnical considerations in the Treatment of Left Main Lesions Ioannis Iakovou, MD, PhD
Technical considerations in the Treatment of Left Main Lesions Ioannis Iakovou, MD, PhD Onassis Cardiac Surgery Center, Athens, Greece Critical issues in LM PCI Anatomic variability Techniques Variability
More informationPathology of percutaneous interventions (PCI) in coronary arteries. Allard van der Wal, MD.PhD; Pathologie AMC, Amsterdam, NL
Pathology of percutaneous interventions (PCI) in coronary arteries Allard van der Wal, MD.PhD; Pathologie AMC, Amsterdam, NL Percutaneous Coronary Intervention (PCI) Definition: transcatheter opening of
More informationEffect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki Hong, MD. PhD on behalf of the IVUS-XPL trial investigators
More informationClinical Characteristics of In-stent Neoatherosclerosis Causing Late Stent Failure
Original Paper J Jpn Coron Assoc 2016; 22: 245-250 Clinical Characteristics of In-stent Neoatherosclerosis Causing Late Stent Failure Koji Isodono, Akiko Matsuo, Atsushi Kyodo, Yumika Tsuji, Akira Sakamoto,
More informationThe Pathology of Neoatherosclerosis in Human Coronary Implants
Journal of the American College of Cardiology Vol. 57, No. 11, 2011 2011 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2011.01.011
More informationBIOFREEDOM: Polymer free Biolimus A9 eluting
TCTAP 2011 Seoul, April 27 29, 2011 BIOFREEDOM: Polymer free Biolimus A9 eluting Stents and Paclitaxel eluting stents Eberhard Grube MD, FACC, FSCAI Hospital Oswaldo Cruz - Dante Pazzanese, São Paulo,
More informationUpgrade of Recommendation
Challenges in LM PCI Decision-making process for stenting Young-Hak Kim, MD, PhD, Heart Institute, University of Ulsan College of Medicine Asan Medical Center, Seoul, Korea Upgrade of Recommendation for
More informationLM stenting - Cypher
LM stenting - Cypher Left main stenting with BMS Since 1995 Issues in BMS era AMC Restenosis and TLR (%) 3 27 TLR P=.282 Restenosis P=.71 28 2 1 15 12 Ostium 5 4 Shaft Bifurcation Left main stenting with
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/64938 holds various files of this Leiden University dissertation. Author: Liu, S. Title: Optical coherence tomography for coronary artery disease : analysis
More informationIntervention: How and to which extent is technology helping us?
Cardiological Society of India Congress 12th February 2016 Chennai, India Intervention: How and to which extent is technology helping us? SIMONE BISCAGLIA MD CARDIOVASCULAR INSTITUTE, FERRARA, ITALY Introduction
More informationGary S. Mintz,, MD. IVUS Observations in Acute (vs Chronic) Coronary Artery Disease: Structure vs Function
Gary S. Mintz,, MD IVUS Observations in Acute (vs Chronic) Coronary Artery Disease: Structure vs Function Important IVUS Observations: Remodeling Originally used (first by Glagov) ) to explain atherosclerosis
More informationVery late thrombosis of sirolimus-eluting stent due to late malapposition: Serial observations with optical coherence tomography
Journal of Cardiology (2008) 52, 290 295 CASE REPORT Very late thrombosis of sirolimus-eluting stent due to late malapposition: Serial observations with optical coherence tomography Takahiro Sawada (MD),
More information